147 related articles for article (PubMed ID: 32002125)
1. A novel function of AAA-ATPase p97/VCP in the regulation of cell motility.
Khong ZJ; Lai SK; Koh CG; Geifman-Shochat S; Li HY
Oncotarget; 2020 Jan; 11(1):74-85. PubMed ID: 32002125
[TBL] [Abstract][Full Text] [Related]
2. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
Liu S; Fu QS; Zhao J; Hu HY
Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
[TBL] [Abstract][Full Text] [Related]
3. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
Weihl CC; Dalal S; Pestronk A; Hanson PI
Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
[TBL] [Abstract][Full Text] [Related]
4. Essential function of VCP/p97 in infection cycle of the nucleopolyhedrovirus AcMNPV in Spodoptera frugiperda Sf9 cells.
Lyupina YV; Erokhov PA; Kravchuk OI; Finoshin AD; Abaturova SB; Orlova OV; Beljelarskaya SN; Kostyuchenko MV; Mikhailov VS
Virus Res; 2018 Jul; 253():68-76. PubMed ID: 29890203
[TBL] [Abstract][Full Text] [Related]
5. A novel HDAC6 inhibitor Tubastatin A: Controls HDAC6-p97/VCP-mediated ubiquitination-autophagy turnover and reverses Temozolomide-induced ER stress-tolerance in GBM cells.
Li ZY; Zhang C; Zhang Y; Chen L; Chen BD; Li QZ; Zhang XJ; Li WP
Cancer Lett; 2017 Apr; 391():89-99. PubMed ID: 28131906
[TBL] [Abstract][Full Text] [Related]
6. Regulation of ER-associated degradation via p97/VCP-interacting motif.
Ballar P; Fang S
Biochem Soc Trans; 2008 Oct; 36(Pt 5):818-22. PubMed ID: 18793143
[TBL] [Abstract][Full Text] [Related]
7. p97/VCP promotes Cullin-RING-ubiquitin-ligase/proteasome-dependent degradation of IκBα and the preceding liberation of RelA from ubiquitinated IκBα.
Schweitzer K; Pralow A; Naumann M
J Cell Mol Med; 2016 Jan; 20(1):58-70. PubMed ID: 26463447
[TBL] [Abstract][Full Text] [Related]
8. Role of p97/VCP (Cdc48) in genome stability.
Vaz B; Halder S; Ramadan K
Front Genet; 2013; 4():60. PubMed ID: 23641252
[TBL] [Abstract][Full Text] [Related]
9. A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization.
Erzurumlu Y; Kose FA; Gozen O; Gozuacik D; Toth EA; Ballar P
Int J Biochem Cell Biol; 2013 Apr; 45(4):773-82. PubMed ID: 23333620
[TBL] [Abstract][Full Text] [Related]
10. Valosin-containing protein VCP/p97 is essential for the intracellular development of Leishmania and its survival under heat stress.
Guedes Aguiar B; Padmanabhan PK; Dumas C; Papadopoulou B
Cell Microbiol; 2018 Oct; 20(10):e12867. PubMed ID: 29895095
[TBL] [Abstract][Full Text] [Related]
11. A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase.
Segura-Cabrera A; Tripathi R; Zhang X; Gui L; Chou TF; Komurov K
Sci Rep; 2017 Mar; 7():44912. PubMed ID: 28322292
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial function in neuronal cells depends on p97/VCP/Cdc48-mediated quality control.
Fang L; Hemion C; Pinho Ferreira Bento AC; Bippes CC; Flammer J; Neutzner A
Front Cell Neurosci; 2015; 9():16. PubMed ID: 25698929
[TBL] [Abstract][Full Text] [Related]
13. Chaperone-Mediated Regulation of Choline Acetyltransferase Protein Stability and Activity by HSC/HSP70, HSP90, and p97/VCP.
Morey TM; Winick-Ng W; Seah C; Rylett RJ
Front Mol Neurosci; 2017; 10():415. PubMed ID: 29311808
[TBL] [Abstract][Full Text] [Related]
14. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.
Wójcik C; Rowicka M; Kudlicki A; Nowis D; McConnell E; Kujawa M; DeMartino GN
Mol Biol Cell; 2006 Nov; 17(11):4606-18. PubMed ID: 16914519
[TBL] [Abstract][Full Text] [Related]
15. VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy.
Lan B; Chai S; Wang P; Wang K
Curr Mol Med; 2017; 17(9):608-618. PubMed ID: 29521227
[TBL] [Abstract][Full Text] [Related]
16. BRSK2 is a valosin-containing protein (VCP)-interacting protein that affects VCP functioning in endoplasmic reticulum-associated degradation.
Wang Y; Wan B; Zhou J; Li R; Yu L
Biotechnol Lett; 2013 Dec; 35(12):1983-9. PubMed ID: 23907667
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of VCP/p97 in cardiovascular diseases: novel insights and therapeutic opportunities.
Shu H; Peng Y; Hang W; Zhou N; Wang DW
Biochem Soc Trans; 2021 Feb; 49(1):485-494. PubMed ID: 33439255
[TBL] [Abstract][Full Text] [Related]
18. Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions.
Wang Q; Song C; Li CC
J Struct Biol; 2004; 146(1-2):44-57. PubMed ID: 15037236
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of human FAF1 UBX domain reveals a novel FcisP touch-turn motif in p97/VCP-binding region.
Kang W; Yang JK
Biochem Biophys Res Commun; 2011 Apr; 407(3):531-4. PubMed ID: 21414298
[TBL] [Abstract][Full Text] [Related]
20. The ATPase VCP/p97 functions as a disaggregase against toxic Huntingtin-exon1 aggregates.
Ghosh DK; Roy A; Ranjan A
FEBS Lett; 2018 Aug; 592(16):2680-2692. PubMed ID: 30069866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
